The linked FDA records identify CooperVision, Inc. as the applicant on P080011, approved on November 19, 2008 for BIOFINITY (comfilcon A) soft contact lenses, classified as soft contact lenses for extended wear under regulation 886.5925. The same PMA number carries a later supplement, P080011/S204, decided September 2, 2026 as a 30-day notice for a process change involving a new density meter at a Juana Diaz, Puerto Rico facility. Two enforcement records list CooperVision, Inc. as the recalling firm. The collection counts below describe only the supplied filings retrieved as of November 20, 2026, not total company output or safety performance. [1][2][4]
The P080011 approval and its stated scope
The original approval order describes BIOFINITY (comfilcon A) sphere and aspheric soft contact lenses for correction of ametropia in aphakic and non-aphakic persons with non-diseased eyes, and states that the lenses may be prescribed for extended wear for up to six nights and seven days of continuous wear, with evaluation on a daily wear schedule first recommended. The summary of safety and effectiveness lists the device generic name as comfilcon A soft (hydrophilic) contact lens and trade names BIOFINITY, Aquaclear and SiH48, and records the applicant as CooperVision, Inc. at a Pleasanton, California address. CDRH issued the approval order on November 19, 2008 after inspecting the applicant's manufacturing facilities for Quality System compliance. [2][6]
A 2026 manufacturing supplement
Supplement P080011/S204 was received August 7, 2026 and decided September 2, 2026 under decision code OK30, with supplement type listed as a 30-day notice and reason given as a process change affecting manufacturer, sterilizer, packager or supplier. The associated statement describes introduction of a new density meter at the Juana Diaz, Puerto Rico facility. The record carries the same trade name, product code LPM and Ophthalmic advisory committee as the original approval. The supplied collection shows two linked PMA records in total, one OK30 and one APPR, while the smaller record sample of two rows shows the same one-and-one split. [1][2]
Recalls naming CooperVision as recalling firm
Two enforcement records list CooperVision, Inc. of West Henrietta, New York as the recalling firm. Recall Z-3248-2026, classified Class II and reported September 30, 2026, covers Pearle Vision 1 day (somofilcon A) contact lenses, with a stated quantity of 3,060 and a reason that a small number of lenses within the affected lot are of the incorrect power; distribution is listed for Minnesota, Ohio and Wisconsin. Recall Z-0204-2027 concerns Softmed Breathables Advanced Toric (fanfilcon A) lenses, described as a 55% water content toric silicone hydrogel lens for daily wear and frequent replacement, and states that an extended-wear statement should not have appeared on the affected carton labeling because the product is not approved for extended wear. Neither recall record names BIOFINITY. [3][4]
Brand material and what the filings do not establish
CooperVision's own practitioner page for Biofinity and Biofinity XR states that the two products together offer sphere powers from +15.00D to -20.00D and cites company data on file for its comfort and prescription-coverage statements; those are the publisher's claims, not FDA findings. The linked FDA records do not establish ownership, a parent company, headquarters, customers or commercial availability beyond what the filings state, and the addresses appearing in FDA records are filing addresses rather than a verified headquarters. [9]








